Strangfeld A, Schafer M, Gianfrancesco MA, Lawson-Tovey S, Liew JW, Ljung L, Mateus EF, Richez C, Santos MJ, Schmajuk G, Scire CA, Sirotich E, Sparks JA, Sufka P, Thomas T, Trupin L, Wallace ZS, Al-Adely S, Bachiller-Corral J, Bhana S, Cacoub P, Carmona L, Costello R, Costello W, Gossec L, Grainger R, Hachulla E, Hasseli R, Hausmann JS, Hyrich KL, Izadi Z, Jacobsohn L, Katz P, Kearsley-Fleet L, Robinson PC, Yazdany J, Machado PM, Alliance C-GR (2021) Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis 80(7):930–942. https://doi.org/10.1136/annrheumdis-2020-219498

Article  CAS  PubMed  Google Scholar 

Conway R, Grimshaw AA, Konig MF, Putman M, Duarte-Garcia A, Tseng LY, Cabrera DM, Chock YPE, Degirmenci HB, Duff E, Egeli BH, Graef ER, Gupta A, Harkins P, Hoyer BF, Jayatilleke A, Jin S, Kasia C, Khilnani A, Kilian A, Kim AHJ, Lin CMA, Low C, Proulx L, Sattui SE, Singh N, Sparks JA, Tam H, Ugarte-Gil MF, Ung N, Wang K, Wise LM, Yang Z, Young KJ, Liew JW, Grainger R, Wallace ZS, Hsieh E, Alliance C-GR (2022) SARS-CoV-2 infection and COVID-19 outcomes in rheumatic diseases: a systematic literature review and meta-analysis. Arthritis Rheumatol 74(5):766–775. https://doi.org/10.1002/art.42030

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang W, Sun X, Fan R, Xu LX, Tang JP (2023) Clinical characteristics of moderate or severe COVID-19 infection in patients with rheumatic diseases and analysis of risk factors leading to severe disease. Int J Rheum Dis. https://doi.org/10.1111/1756-185x.14844

Article  PubMed  Google Scholar 

Feikin DR, Higdon MM, Andrews N, Collie S, Deloria Knoll M, Kwong JC, Link-Gelles R, Pilishvili T, Patel MK (2023) Assessing COVID-19 vaccine effectiveness against Omicron subvariants: report from a meeting of the World Health Organization. Vaccine. https://doi.org/10.1016/j.vaccine.2023.02.020

Article  PubMed  PubMed Central  Google Scholar 

Wang H, Yu B, Chen X, Yan H (2023) Global pattern and determinants of coronavirus disease 2019 (COVID-19) vaccine coverage and progression: a global ecological study. Glob Health J 7(1):18–23. https://doi.org/10.1016/j.glohj.2023.02.003

Article  PubMed  PubMed Central  Google Scholar 

Curtis JR, Johnson SR, Anthony DD, Arasaratnam RJ, Baden LR, Bass AR, Calabrese C, Gravallese EM, Harpaz R, Kroger A, Sadun RE, Turner AS, Williams EA, Mikuls TR (2023) American College of Rheumatology guidance for COVID-19 vaccination in patients with rheumatic and musculoskeletal diseases: version 5. Arthritis Rheumatol 75(1):E1–E16. https://doi.org/10.1002/art.42372

Article  PubMed  Google Scholar 

Diseases CSoI, Association CM, Rheumatology CSo, Association CM (2021) Expert recommendation on severe acute respiratory syndrome coronavirus 2 vaccination in patients with chronic liver diseases, tuberculosis or rheumatoid diseases. Infect Dis Immunity 1(3):137–143. https://doi.org/10.1097/ID9.0000000000000021

Article  Google Scholar 

Boekel L, Hooijberg F, van Kempen ZLE, Vogelzang EH, Tas SW, Killestein J, Nurmohamed MT, Boers M, Kuijpers TW, van Ham SM, Eftimov F, Wieske L, Rispens T, Wolbink GJ (2021) Perspective of patients with autoimmune diseases on COVID-19 vaccination. Lancet Rheumatol 3(4):e241–e243. https://doi.org/10.1016/S2665-9913(21)00037-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Szekanecz Z, Balog A, Constantin T, Czirjak L, Geher P, Kovacs L, Kumanovics G, Nagy G, Rakoczi E, Szamosi S, Szucs G, Valyi-Nagy I (2022) COVID-19: autoimmunity, multisystemic inflammation and autoimmune rheumatic patients. Expert Rev Mol Med 24:e13. https://doi.org/10.1017/erm.2022.10

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xie Y, Liu Y, Liu Y (2022) The flare of rheumatic disease after SARS-CoV-2 vaccination: a review. Front Immunol 13:919979. https://doi.org/10.3389/fimmu.2022.919979

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pinte L, Negoi F, Ionescu GD, Caraiola S, Balaban DV, Badea C, Mazilu D, Dumitrescu B, Mateescu B, Ionescu R, Parvu MI, Baicus C (2021) COVID-19 vaccine does not increase the risk of disease flare-ups among patients with autoimmune and immune-mediated diseases. J Pers Med. https://doi.org/10.3390/jpm11121283

Article  PubMed  PubMed Central  Google Scholar 

Sattui SE, Liew JW, Kennedy K, Sirotich E, Putman M, Moni TT, Akpabio A, Alpizar-Rodriguez D, Berenbaum F, Bulina I, Conway R, Singh AD, Duff E, Durrant KL, Gheita TA, Hill CL, Howard RA, Hoyer BF, Hsieh E, El Kibbi L, Kilian A, Kim AH, Liew DFL, Lo C, Miller B, Mingolla S, Nudel M, Palmerlee CA, Singh JA, Singh N, Ugarte-Gil MF, Wallace J, Young KJ, Bhana S, Costello W, Grainger R, Machado PM, Robinson PC, Sufka P, Wallace ZS, Yazdany J, Harrison C, Larche M, Levine M, Foster G, Thabane L, Rider LG, Hausmann JS, Simard JF, Sparks JA (2021) Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey. RMD Open. https://doi.org/10.1136/rmdopen-2021-001814

Article  PubMed  Google Scholar 

Sharma A, Minh Duc NT, Luu Lam Thang T, Nam NH, Ng SJ, Abbas KS, Huy NT, Marušić A, Paul CL, Kwok J, Karbwang J, de Waure C, Drummond FJ, Kizawa Y, Taal E, Vermeulen J, Lee GHM, Gyedu A, To KG, Verra ML, Jacqz-Aigrain ÉM, Leclercq WKG, Salminen ST, Sherbourne CD, Mintzes B, Lozano S, Tran US, Matsui M, Karamouzian M (2021) A consensus-based checklist for reporting of survey studies (CROSS). J Gen Intern Med 36(10):3179–3187. https://doi.org/10.1007/s11606-021-06737-1

Article  PubMed  PubMed Central  Google Scholar 

Li YK, Lui MPK, Yam LL, Cheng CS, Tsang THT, Kwok WS, Chung HY (2022) COVID-19 vaccination in patients with rheumatic diseases: vaccination rates, patient perspectives, and side effects. Immun Inflamm Dis 10(3):e589. https://doi.org/10.1002/iid3.589

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mohanasundaram K, Santhanam S, Natarajan R, Murugesan H, Nambi T, Chilikuri B, Nallasivan S (2022) Covid-19 vaccination in autoimmune rheumatic diseases: a multi-center survey from southern India. Int J Rheum Dis 25(9):1046–1052. https://doi.org/10.1111/1756-185X.14378

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chevet B, Figueroa-Parra G, Yang JX, Hulshizer CA, Gunderson TM, Duong SQ, Putman MS, Barbour KE, Crowson CS, Duarte-Garcia A (2022) COVID-19 vaccine uptake among patients with systemic lupus erythematosus in the American Midwest: the Lupus Midwest Network (LUMEN). J Rheumatol 49(11):1276–1282. https://doi.org/10.3899/jrheum.220220

Article  CAS  PubMed  PubMed Central  Google Scholar 

Widdifield J, Eder L, Chen S, Kwong JC, Hitchon C, Lacaille D, Avina-Zubieta JA, Svenson LW, Bernatsky S (2022) COVID-19 vaccination uptake among individuals with immune-mediated inflammatory diseases in Ontario, Canada, between December 2020 and October 2021: a population-based analysis. J Rheumatol 49(5):531–536. https://doi.org/10.3899/jrheum.211148

Article  CAS  PubMed  Google Scholar 

Teijaro JR, Farber DL (2021) COVID-19 vaccines: modes of immune activation and future challenges. Nat Rev Immunol 21(4):195–197. https://doi.org/10.1038/s41577-021-00526-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gil-Vila A, Ravichandran N, Selva-O’Callaghan A, Sen P, Nune A, Gaur PS, Gonzalez RA, Lilleker JB, Joshi M, Agarwal V, Kardes S, Kim M, Day J, Makol A, Milchert M, Gheita T, Salim B, Velikova T, Gracia-Ramos AE, Parodis I, Nikiphorou E, Tan AL, Chatterjee T, Cavagna L, Saavedra MA, Shinjo SK, Ziade N, Knitza J, Kuwana M, Distler O, Chinoy H, Agarwal V, Aggarwal R, Gupta L, Group CS (2022) COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies. Muscle Nerve 66(4):426–437. https://doi.org/10.1002/mus.27681

Article  CAS  PubMed  PubMed Central  Google Scholar 

Connolly CM, Ruddy JA, Boyarsky BJ, Barbur I, Werbel WA, Geetha D, Garonzik-Wang JM, Segev DL, Christopher-Stine L, Paik JJ (2022) Disease flare and reactogenicity in patients with rheumatic and musculoskeletal diseases following two-dose SARS-CoV-2 messenger RNA vaccination. Arthritis Rheumatol 74(1):28–32. https://doi.org/10.1002/art.41924

Article  CAS  PubMed  Google Scholar 

Barbhaiya M, Levine JM, Bykerk VP, Jannat-Khah D, Mandl LA (2021) Systemic rheumatic disease flares after SARS-CoV-2 vaccination among rheumatology outpatients in New York City. Ann Rheum Dis 80(10):1352–1354. https://doi.org/10.1136/annrheumdis-2021-220732

Article  CAS  PubMed  Google Scholar 

Fong W, Woon TH, Chew LC, Low A, Law A, Poh YJ, Yeo SI, Leung YY, Ma M, Santosa A, Kong KO, Xu C, Teng GG, Mak A, Tay SH, Chuah TY, Roslan NE, Angkodjojo S, Phang KF, Sriranganathan M, Tan TC, Cheung P, Lahiri M (2023) Prevalence and factors associated with flares following COVID-19 mRNA vaccination in patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: a national cohort study. Adv Rheumatol 63(1):38. https://doi.org/10.1186/s42358-023-00316-0

Article  PubMed  Google Scholar 

Rider LG, Parks CG, Wilkerson J, Schiffenbauer AI, Kwok RK, Noroozi Farhadi P, Nazir S, Ritter R, Sirotich E, Kennedy K, Larche MJ, Levine M, Sattui SE, Liew JW, Harrison CO, Moni TT, Miller AK, Putman M, Hausmann J, Simard JF, Sparks JA, Miller FW, Group C-GRAVS (2022) Baseline factors associated with self-reported disease flares following COVID-19 vaccination among adults with systemic rheumatic disease: results from the COVID-19 global rheumatology alliance vaccine survey. Rheumatology (Oxford) 61(SI2):SI143–SI150. https://doi.org/10.1093/rheumatology/keac249

Article  PubMed  Google Scholar 

Li X, Tong X, Yeung WWY, Kuan P, Yum SHH, Chui CSL, Lai FTT, Wan EYF, Wong CKH, Chan EWY, Lau CS, Wong ICK (2022) Two-dose COVID-19 vaccination and possible arthritis flare among patients with rheumatoid arthritis in Hong Kong. Ann Rheum Dis 81(4):564–568. https://doi.org/10.1136/annrheumdis-2021-221571

Article  CAS  PubMed  Google Scholar 

Abu-Raddad LJ, Chemaitelly H, Ayoub HH, AlMukdad S, Yassine HM, Al-Khatib HA, Smatti MK, Tang P, Hasan MR, Coyle P, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt AA, Al-Romaihi HE, Al-Thani MH, Al-Khal A, Bertollini R (2022) Effect of mRNA vaccine boosters against SARS-CoV-2 Omicron infection in Qatar. N Engl J Med 386(19):1804–1816. https://doi.org/10.1056/NEJMoa2200797

Article  CAS  PubMed  Google Scholar 

Chan LE, Casiraghi E, Laraway B, Coleman B, Blau H, Zaman A, Harris NL, Wilkins K, Antony B, Gargano M, Valentini G, Sahner D, Haendel M, Robinson PN, Bramante C, Reese J, consortium NC (2022) Metformin is associated with reduced COVID-19 severity in patients with prediabetes. Diabetes Res Clin Pract 194:110157. https://doi.org/10.1016/j.diabres.2022.110157

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bramante CT, Buse J, Tamaritz L, Palacio A, Cohen K, Vojta D, Liebovitz D, Mitchell N, Nicklas J, Lingvay I, Clark JM, Aronne LJ, Anderson E, Usher M, Demmer R, Melton GB, Ingraham N, Tignanelli CJ (2021) Outpatient metformin use is associated with reduced severity of COVID-19 disease in adults with overweight or obesity. J Med Virol 93(7):4273–4279.